These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1859516)

  • 1. Pharmacokinetics of omeprazole in cirrhotic patients.
    Rinetti M; Regazzi MB; Villani P; Tizzoni M; Sivelli R
    Arzneimittelforschung; 1991 Apr; 41(4):420-2. PubMed ID: 1859516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary study.
    Morgan MY; Stambuk D
    Postgrad Med J; 1986; 62 Suppl 2():29-37. PubMed ID: 2890149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable omeprazole kinetics in healthy Jordanian adults.
    Albsoul-Younes A; Tayyem R; Najib N
    Biopharm Drug Dispos; 2005 Jul; 26(5):183-8. PubMed ID: 15906422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: an open-label, randomized, crossover, pharmacokinetic interaction clinical trial.
    Portolés A; Calvo A; Terleira A; Laredo L; Resplandy G; Gorostiaga C; Moreno A
    J Clin Pharmacol; 2006 Oct; 46(10):1195-203. PubMed ID: 16988209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of gastric pH on the pharmacokinetics of fluconazole: the effect of omeprazole.
    Zimmermann T; Yeates RA; Riedel KD; Lach P; Laufen H
    Int J Clin Pharmacol Ther; 1994 Sep; 32(9):491-6. PubMed ID: 7820333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state pharmacokinetics of once-daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers.
    Luber AD; Brower R; Kim D; Silverman R; Peloquin CA; Frank I
    HIV Med; 2007 Oct; 8(7):457-64. PubMed ID: 17760738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of oral omeprazole in llamas.
    Poulsen KP; Smith GW; Davis JL; Papich MG
    J Vet Pharmacol Ther; 2005 Dec; 28(6):539-43. PubMed ID: 16343286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers.
    Phillips JO; Olsen KM; Rebuck JA; Rangnekar NJ; Miedema BW; Metzler MH
    Am J Gastroenterol; 2001 Feb; 96(2):367-72. PubMed ID: 11232677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of omeprazole on the pharmacokinetics of paricalcitol in healthy subjects.
    Palaparthy R; Pradhan RS; Chan J; Rieser M; Chira T; Galitz L; Awni W; Williams LA
    Biopharm Drug Dispos; 2007 Mar; 28(2):65-71. PubMed ID: 17173278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests.
    Brockmöller J; Thomsen T; Wittstock M; Coupez R; Lochs H; Roots I
    Clin Pharmacol Ther; 2005 Jun; 77(6):529-41. PubMed ID: 15961984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease.
    Periclou AP; Goldwater R; Lee SM; Park DW; Kim DY; Cho KD; Boileau F; Jung WT
    Clin Pharmacol Ther; 2000 Sep; 68(3):304-11. PubMed ID: 11014412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of age on the pharmacokinetics of naftidrofuryl after single oral administration in elderly versus young healthy volunteers.
    Hulot T; Gamand S; Dupain T; Ahtoy P; Bromet M
    Arzneimittelforschung; 1998 Sep; 48(9):900-4. PubMed ID: 9793615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers.
    Winston A; Back D; Fletcher C; Robinson L; Unsworth J; Tolowinska I; Schutz M; Pozniak AL; Gazzard B; Boffito M
    AIDS; 2006 Jun; 20(10):1401-6. PubMed ID: 16791014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic studies of cefuroxime in patients with liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Xerri L; Pugina M
    Arzneimittelforschung; 1982; 32(7):777-82. PubMed ID: 6889880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic disposition of isoxicam in hepatic cirrhosis.
    Esquivel M; Ogilvie RI; East DS; Shaw DH; Heathcote J
    Clin Invest Med; 1987 Sep; 10(5):363-7. PubMed ID: 3677504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of [14C]omeprazole in patients with liver cirrhosis.
    Andersson T; Olsson R; Regårdh CG; Skånberg I
    Clin Pharmacokinet; 1993 Jan; 24(1):71-8. PubMed ID: 8448974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of omeprazole in patients with liver cirrhosis and extrahepatic portal venous obstruction.
    Kumar R; Chawla YK; Garg SK; Dixit RK; Satapathy SK; Dhiman RK; Bhargava VK
    Methods Find Exp Clin Pharmacol; 2003 Oct; 25(8):625-30. PubMed ID: 14671680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis.
    Spreux-Varoquaux O; Doll J; Dutot C; Grandjean N; Cordonnier P; Pays M; Andrieu J; Advenier C
    Br J Clin Pharmacol; 1991 Sep; 32(3):399-401. PubMed ID: 1777378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of famotidine in patients with cirrhosis and ascites.
    Vinçon G; Baldit C; Couzigou P; Demotes-Mainard F; Elouaer-Blanc L; Bannwarth B; Begaud B
    Eur J Clin Pharmacol; 1992; 43(5):559-62. PubMed ID: 1483496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastric protein loss and alcoholic cirrhosis. Study by measurement of gastric clearance of alpha 1-antitrypsin].
    Becheur H; Pauwels A; Mostefa-Kara N; Degoutte E; Fourdan O; Akrour O; Lévy VG; Florent C
    Gastroenterol Clin Biol; 1996; 20(8-9):669-73. PubMed ID: 8977815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.